Leaderboard

Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Leber » Anderes 21. Oktober 2025
Suchen
Gastroplattform
Anderes
Erweiterte Suche
Abklärungen / Diagnostik
Therapien
Guidelines
Fortbildung
News / Journalscreening
Fachliteratursuche
Gallenwege
Leber
Hepatitis
Leberzirrhose
Neoplasie
Portale Hypertonie
Anderes
Magen-Darm
Oesophagus
Pankreas
Kongresse / Tagungen
Services / Tools
Links
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 3599  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 71974  
   
County-Level Factors and Preventable Premature Liver Mortality in Metabolic Dysfunction-Associated Steatotic Liver Disease.
JAMA Netw Open
Paik JM, Zelber-Sagi S, Paik A, Henry L, Yilmaz Y, El-Kassas M, Alqahtani SA, Younossi ZM.
PMID: 41114974 [PubMed - indexed for MEDLINE]


A Systematic Review of Population Pharmacokinetics, Safety, and Factors Influencing Trough Concentrations of Voriconazole in Asian Patients with Liver Dysfunction.
Drug Des Devel Ther
Hu L, Wang C, Huang S, Tang X, Li Y.
PMID: 41114283 [PubMed - indexed for MEDLINE]


ECM remodeling in hypothyroidism-associated MAFLD: mechanisms, clinical relevance, and therapeutic targets.
Front Immunol
Wang T, Duan L, Zhao B, Zhang J, Yu Y, Zhao J.
PMID: 41112248 [PubMed - indexed for MEDLINE]


Beyond biomarkers: An integrated traditional Chinese medicine-machine learning approach predicts hepatic steatosis in high metabolic risk populations.
World J Gastroenterol
Guo YC, Hong Y, Huang L, Xu XW, Sun JQ, Ji KK, Li CN.
PMID: 41112009 [PubMed - indexed for MEDLINE]


Multimodal artificial intelligence technology in the precision diagnosis and treatment of gastroenterology and hepatology: Innovative applications and challenges.
World J Gastroenterol
Wu YM, Tang FY, Qi ZX.
PMID: 41112005 [PubMed - indexed for MEDLINE]


Comprehensive evaluation of high dose methotrexate therapy: a retrospective observational trial.
J Egypt Natl Canc Inst
Ehab Barakat H, Ashraf El Bahy K, Victor Labib S, Zakaria Aldesouky Y, Ayman Ismail A, El Sayed Mohamed M, Louis Sedky F, Mohamed Abdelhady A, Hamdy Gaballah D, Ashraf Ali D, Mohamed Refaat P, Al Sayed Mohamed H, Zayed Mohamed A, Selim Ibrahim S, M Noreddin A, M Osman AM, M Abdelkeriem E, M Sayed-Ahmed M, M Karkeet R.
PMID: 41111074 [PubMed - indexed for MEDLINE]


Pediatric Liver Diseases: Next-Generation Therapies.
Clin Liver Dis
Teckman J, Bagwe A.
PMID: 41109702 [PubMed - indexed for MEDLINE]


Artificial Intelligence and Machine Learning Applications in Liver Disease.
Clin Liver Dis
Vemulapalli B, Ghattu M, Atluri K, Lee J, Rustgi V.
PMID: 41109701 [PubMed - indexed for MEDLINE]


Current and Future Implications of Weight Loss Drugs on Liver Disease.
Clin Liver Dis
Bussetty A, Shah N, Chandler TM, Ghattu M, Kesavarapu K.
PMID: 41109700 [PubMed - indexed for MEDLINE]


Liver-Directed Molecular Therapies: Current and Upcoming Strategies.
Clin Liver Dis
Asp P, Malachowska B, Guha C, Roy-Chowdhury J.
PMID: 41109692 [PubMed - indexed for MEDLINE]


Relationship between MASLD and women's health: A review.
Womens Health (Lond)
Jancova P, Ismail K, Vistejnova L.
PMID: 41108032 [PubMed - indexed for MEDLINE]


Austrian multisociety consensus on metabolic dysfunction-associated steatotic liver disease : Austrian Society of Gastroenterology and Hepatology (ÖGGH), Austrian Society of Diabetology (ÖDG), Austrian Society of Obesity (ÖAG).
Wien Klin Wochenschr
Mandorfer M, Semmler G, Aigner E, Bräuer A, Maria Brix J, Clodi M, Datz C, Effenberger M, Moritz Felsenreich D, Ludvik B, Maieron A, Peck-Radosavljevic M, Ress C, Scherzer TM, Sourij H, Stechemesser L, Tilg H, Trauner M, Wagner M, Hofer H, Kiefer FW, Fasching P, Roden M.
PMID: 41107485 [PubMed - indexed for MEDLINE]


Metabolic dysfunction-associated steatotic liver disease (MASLD) can be a possible predictive factor of incident CKD: NAGALA cohort study.
PLoS One
Ono Y, Sakai K, Okamura T, Okada H, Obora A, Kojima T, Hamaguchi M, Fukui M.
PMID: 41105669 [PubMed - indexed for MEDLINE]


Circadian clock genes: Their influence on liver metabolism, disease development and treatment (Review).
Mol Med Rep
Wang J, Cao M, Li S, Pei W, Li J, Wang Z.
PMID: 41104881 [PubMed - indexed for MEDLINE]


Metabolic dysfunction‑associated steatotic liver disease: Pathogenesis, model and treatment (Review).
Int J Mol Med
Ma Q, Liu K, Chang C, Wang L, Shen Z, Li J, Adu M, Lin Q, Huang H, Wu X, Wei R.
PMID: 41104870 [PubMed - indexed for MEDLINE]


Multi-omics analysis of hepatic outcomes in T2DM-MAFLD patients treated with semaglutide: a single-centre, longitudinal, data-driven study.
Front Endocrinol (Lausanne)
Niu S, Chen S, Wu D, Wang C, Xu J, Yin J, Zhao Y.
PMID: 41103643 [PubMed - indexed for MEDLINE]


Integrated proteomics and single-cell transcriptomics reveal potential therapeutic targets in Wilson's disease patients.
Front Immunol
Qi Y, Sun M, Xu F, Zhou H, Yuan L, Yu X, Cao S, Hua R.
PMID: 41103426 [PubMed - indexed for MEDLINE]


Total bile acid concentrations and adverse perinatal outcomes in chinese intrahepatic cholestasis of pregnancy including asymptomatic hypercholanemia of pregnancy: a retrospective cohort study.
BMC Pregnancy Childbirth
Yao L, Zhou J, Tan Z, Li C, He T, Yin Y, Zhang P.
PMID: 41102717 [PubMed - indexed for MEDLINE]


Examining the implementation of home-based palliative care for patients with end-stage liver disease (HoPE): a protocol for a feasibility study.
BMJ Open
Nah CY, Yip W, Kaliyaperumal K, Yung SH, Chia SC, Hum A.
PMID: 41101957 [PubMed - indexed for MEDLINE]


Nonlinear association between TyG-BMI and MAFLD: A cross-sectional study.
PLoS One
Wang Q, Su Y, Niu J, Wang Y, Liu L, Hao Y.
PMID: 41100462 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 71974    Seite 1 von 3599  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Ironmedline

Das Fachportal für Eisenmangel >>

 

Sky right 1